Arvinas (ARVN) Other Non Operating Income (2017 - 2026)
Arvinas' (ARVN) quarterly Other Non Operating Income came in at -$100000.0 in Q1 2026, up 66.67% quarter-over-quarter from -$300000.0 in Q2 2025.
Arvinas (ARVN) Other Non Operating Income (2017 - 2026) Analysis & Trends
Arvinas' Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$100000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$100000.0 in Q1 2026; TTM through Mar 2026 was -$400000.0, a 86.21% increase from a year earlier, with the FY2025 full-year figure at -$400000.0, up 86.21% from the prior year.
- Other Non Operating Income grew to -$100000.0 in Q1 2026 per ARVN's latest filing, from -$300000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $600000.0 in Q4 2022 and bottomed at -$2.6 million in Q3 2024.
- The 5-year median for Other Non Operating Income is -$100000.0 (2022), against an average of -$390909.1.
- Across the five-year window, Other Non Operating Income fell 25.0% in 2022 and tumbled 1000.0% in 2023, its largest moves.
- Year by year, Other Non Operating Income stood at $600000.0 in 2022, then sank by 116.67% to -$100000.0 in 2023, then plunged by 100.0% to -$200000.0 in 2024, then sank by 50.0% to -$300000.0 in 2025, then jumped by 66.67% to -$100000.0 in 2026.
- Per Business Quant, the three latest ARVN Other Non Operating Income figures stand at -$100000.0 (Q1 2026), -$300000.0 (Q2 2025), and -$200000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100,000.00 |
| Jun 30, 2025 | -300,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | -2.60 Mn |
| Jun 30, 2024 | -100,000.00 |
| Dec 31, 2023 | -100,000.00 |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | 600,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 1.20 Mn |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | 144,215.00 |
| Jun 30, 2020 | 307,743.00 |
| Mar 31, 2020 | 390,009.00 |
| Dec 31, 2019 | 595,443.00 |